降脂药物与女性生殖内分泌系统疾病之间的因果关系:针对药物的门德尔随机化研究
Jing Zhao1, Runfang Wang2, Liyun Song1
1Department of Gynecology, Hebei General Hospital, Shijiazhuang, China.
Frontiers in endocrinology
|November 29, 2023
概括
PCSK9 抑制剂可能会增加不孕症风险,而 HMGCR 抑制剂可能会减少阴高潮. 在这项研究中,降脂药物对PCOS,POI,PMS或寡妇没有影响.
科学领域:
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
- 遗传学 遗传学是一种遗传学.
背景情况:
- 脱脂症越来越多地与女性生殖内分泌系统疾病有关.
- 用于治疗冠状动脉疾病等疾病的降脂药物可能会影响女性生殖健康.
- 了解这些药物效应对于安全有效的治疗选择至关重要.
研究的目的:
- 研究特定的降脂药物标对女性生殖内分泌疾病的影响.
- 为妇女选择适当的降脂疗法提供基于证据的指导.
- 分析HMGCR,PCSK9和NPC1L1抑制剂对生殖健康结果的影响.
主要方法:
- 利用孟德尔的随机化 (MR) 分析与全基因组关联研究数据.
- 专注于三个主要的药物标:HMGCR,PCSK9和NPC1L1抑制剂.
- 评估了多囊性卵巢综合征 (PCOS),过早卵巢衰竭 (POI),月经前综合征 (PMS),异常子宫出血 (月经不良,小月经不良) 和不孕症的风险.
主要成果:
- PCSK9抑制剂与不孕症风险显著增加有关 (OR [95%CI] = 1.14 [1.06,1.23]).
- HMGCR 抑制剂显著降低了阴道风险 (OR [95%CI] = 0.85 [0.75,0.97]).
- 没有观察到HMGCR抑制剂对寡妇或对PCOS,POI或PMS的任何研究药物的显著影响.
结论:
- PCSK9抑制剂可能会增加女性不孕症的风险.
- HMGCR 抑制剂显示出潜在的保护性作用,可以防止更年流.
- 目前的证据不支持这些降脂药物标与其他主要的生殖内分泌疾病 (如PCOS或POI) 之间的联系.
相关概念视频
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
671
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
671
01:31Transducer Mechanism: Nuclear Receptors
1.3K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K
01:26Targets for Drug Action: Overview
6.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.3K
01:19Factors Affecting Drug Biotransformation: Biological
154
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
154
01:24Principles of Drug Action
6.0K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
6.0K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
130
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
130